Drug development
and diagnostics

Choose the relevant keywords from the list to search for research groups on those specific areas. As the search is cumulative, choose only a few keywords for a general search and more keywords for more refined search. To see all research groups, click the selection underneath the list.

Clear All
All research groups

Research Groups and R&D Platforms: Biomarker, Biomedicine, Breast cancer, Cancer, Clinical Medicine, Disease models, Drug target, Imaging, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular Biology, PET, Physiology, Preclinical development, Prostate cancer, Squamous cell carcinoma

Research Group:
Preclinical Imaging

Tove Grönroos
tovgro[at]utu.fi

Turku PET Centre,
University of Turku

Tove Grönroos

www.pet.fi

Biomarker, Biomedicine, Breast cancer, Cancer, Clinical Medicine, Disease models, Drug target, Imaging, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular Biology, PET, Physiology, Preclinical development, Prostate cancer, Squamous cell carcinoma

Further information

Pauli Ollikka, Project Coordinator

pauli.ollikka@abo.fi
pauli.ollikka@utu.fi

Drug development and diagnostics is a common research profiling area of the University of Turku and Åbo Akademi University funded by the Academy of Finland. This website is a part of this joint initiative bringing together all information that is related to drug discovery and development or diagnostics from both universities.

Drug developmentand diagnostics

Research Groups and R&D Platforms: Biomarker, Biomedicine, Breast cancer, Cancer, Clinical Medicine, Disease models, Drug target, Imaging, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular Biology, PET, Physiology, Preclinical development, Prostate cancer, Squamous cell carcinoma

Research Group:Preclinical Imaging

Further information

Drug development
and diagnostics

Research Group:
Preclinical Imaging